Skip to main content
. 2020 Oct 1;16(4):361–387. doi: 10.1007/s13181-020-00810-7

Table 14.

Antidepressant agents.

N (%)
Selective serotonin reuptake inhibitors (SSRIs) 381 (38.2)
  Sertraline 126 (12.7)
  Fluoxetine 99 (9.9)
  Escitalopram 74 (7.4)
  Citalopram 55 (5.5)
  Paroxetine 22 (2.2)
  Fluvoxamine 5 (0.5)
Other antidepressants 369 (37.0)
  Bupropion 213 (21.4)
  Trazodone 127 (12.8)
  Mirtazapine 19 (1.9)
  Antidepressant unspecified 7 (0.7)
  Miscellaneousa < 5 (< 0.5)
  Tricyclic antidepressants (TCAs) 117 (11.7)
  Amitriptyline 84 (8.4)
  Nortriptyline 16 (1.6)
  Doxepin 13 (1.3)
  Miscellaneousb < 5 (< 0.5)
Serotonin-norepinephrine reuptake inhibitors (SNRIs) 128 (12.9)
  Venlafaxine 78 (7.8)
  Duloxetine 41 (4.1)
  Desvenlafaxine 7 (0.7)
  Miscellaneousc < 5 (< 0.5)
Monoamine oxidase inhibitor (MAOIs) 1 (0.1)
  Phenelzine 1 (0.1)
  Class total 996 (100)

aIncludes vortioxetine and tranylcypromine

bIncludes protriptyline, clomipramine, desipramine, and noxiptiline

cIncludes milnacipran and levomilnacipran